OTC:INTI | Cash Flow Statement | Inhibitor Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2012-09-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$613,933.00
2026-03-31-$686,425.00-$1.08M
2025-12-31-$1.3M-$601,165.00
2025-09-30-$712,184.00
2025-06-30-$659,942.00
2025-03-31-$632,846.00-$1.28M
2024-12-31-$1.42M-$771,441.00
2024-09-30-$730,957.00
2024-06-30-$501,690.00
2024-03-31-$684,711.00-$1.16M
2023-12-31-$1.17M-$697,706.00$0.00
2023-09-30-$664,760.00
2023-06-30-$654,521.00
2023-03-31-$539,596.00-$757,283.00-$411,000.00
2022-12-31$12.36M$11.9M$0.00
2022-09-30-$77,692.00
2022-06-30-$77,567.00
2022-03-31-$98,910.00-$44,188.00$50,000.00
2021-12-31-$33,561.00-$22,661.00$0.00
2021-09-30-$71,051.00
2021-06-30-$66,182.00
2021-03-31-$127,838.00-$91,870.00$101,000.00
2020-12-31-$55,851.00-$16,648.00$0.00$55,000.00
2020-09-30-$302,767.00
2020-06-30-$314,894.00
2020-03-31-$384,417.00-$501,128.00$0.00
2019-12-31-$635,829.00-$568,370.00$0.00$0.00
2019-09-30-$678,548.00
2019-06-30-$632,691.00
2019-03-31-$786,288.00-$977,989.00$1M
2018-12-31-$1.33M-$832,113.00$500,000.00
2018-09-30-$1.17M
2018-06-30-$881,916.00
2018-03-31-$1.17M-$1.13M$2.36M
2017-12-31-$904,217.00-$543,248.00$0.00
2017-09-30-$679,080.00
2017-06-30-$716,441.00
2017-03-31-$2.8M-$867,878.00
2016-12-31-$2.75M-$1.21M
2016-09-30-$1.73M
2016-06-30-$1.33M
2016-03-31-$1.19M-$482,822.00
2015-12-31-$1.03M-$641,827.00
2015-09-30-$1.2M
2015-06-30-$791,656.00
2015-03-31-$922,674.00-$281,210.00
2014-12-31-$898,083.00-$518,784.00
2014-09-30-$740,069.00
2014-06-30-$2.14M
2014-03-31-$196,488.00-$108,505.00
2013-12-31-$215,169.00-$169,437.00$169,542.00
2013-09-30-$1.29M
2013-06-30-$266,904.00
2013-03-31-$60,545.00-$81,230.00
2012-12-31-$224,587.00-$65,716.00
2012-09-30$640,287.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$3.3M-$3.23M
2024-12-31-$3.34M-$3.23M
2023-12-31-$3.03M-$2.7M-$411,000.00
2022-12-31$12.11M$11.74M$180,000.00
2021-12-31-$298,632.00-$220,433.00$176,000.00
2020-12-31-$1.06M-$825,357.00$0.00$96,600.00
2019-12-31-$2.73M-$2.71M$99,178.00$2.4M
2018-12-31-$4.55M-$3.71M$4.47M
2017-12-31-$5.1M-$2.91M-$3.63M
2016-12-31-$7M-$3.76M
2015-12-31-$3.95M-$2.26M
2014-12-31-$3.98M-$1.3M
2013-12-31-$1.84M-$1.22M$366,130.00
2012-12-31$186,366.00-$464,266.00